GeneImmune Biotechnology Corp. is a leading Contract Research Organization (CRO) specializing in virology research, offering a comprehensive range of services in molecular biology, protein production, bio-assay, and antibody drug development. With a focus on HIV and influenza viruses, GeneImmune utilizes proprietary technologies to develop product lines including anti-viral polyclonal and monoclonal antibodies, as well as viral proteins produced in mammalian cells and E.coli. Their expertise enables the development of subtype-specific diagnostic kits for laboratory detection of viral infections and evaluation of vaccine-induced immune responses, providing valuable insights for scientists studying natural infection and vaccine efficacy. With a proven track record, GeneImmune is a trusted and reliable partner in drug discovery, committed to meeting the demands of developing pre-clinical drug candidates efficiently and cost-effectively. Their innovative approach and dedication to excellence make them an ideal choice for researchers and pharmaceutical companies seeking high-quality biological reagents and services in virology research.Generated from the website

Mylegal.com

Atlantic Nicc Jv LLC

Planet Depos

Plan 3